-+ 0.00%
-+ 0.00%
-+ 0.00%

FormFactor (FORM) Updated Its Outlook, Is The Valuation Still Too Rich?

Simply Wall St·07/30/2026 10:12:33
Listen to the news

FormFactor (FORM) is back in focus after reporting second quarter results and updating its near term outlook, giving investors fresh data on sales, profitability, and expectations for the coming quarter.

See our latest analysis for FormFactor.

Despite FormFactor’s solid earnings update and new partnership announcements, the share price has fallen 26.4% over the past week and 42.1% over the past month. However, year to date the share price return is up 41% and the 1 year total shareholder return is 142.5%, so momentum has recently cooled after a strong run.

If FormFactor’s recent moves have you reassessing semiconductor exposure, this could be a good time to scan the wider chip space using our screener for 56 AI infrastructure stocks

Bulls point to FormFactor’s profit jump and Taiwan partnership, while bears focus on the sharp pullback in the share price. Which side does the current valuation evidence support next?

Most Popular Narrative: 42.3% Undervalued

FormFactor's most followed narrative pegs fair value at $144.67 per share compared with the last close of $83.45, which frames a wide valuation gap that hinges on AI driven chip testing demand and execution at new manufacturing sites.

Accelerating adoption of generative AI, high-performance computing, and HBM DRAM in data centers is driving substantial increases in test complexity and intensity. FormFactor's differentiated probe cards and early leadership in HBM4 chiplet testing position the company to benefit from higher ASPs and revenue growth as these markets scale. (Impacts: Revenue, potential margin improvement)

Read the complete narrative.

Curious what earnings path and margin profile sit behind that fair value and discount rate assumption. The narrative leans heavily on compound revenue growth, rising profitability and a slimmer valuation multiple than many headline AI hardware stocks.

Result: Fair Value of $144.67 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, FormFactor’s story is not risk free, with margin pressure from product mix and higher operating costs, as well as exposure to U.S. and China trade policy changes.

Find out about the key risks to this FormFactor narrative.

Another View on FormFactor’s Valuation

The analyst narrative leans on a fair value of $144.67 per share, yet FormFactor currently trades on a P/E of 95.2x. That is far above the US Semiconductor industry on 47.3x, its peer average of 73.1x, and even a fair ratio of 77.4x, which suggests meaningful valuation risk if expectations slip. How comfortable are you paying that kind of premium for this growth story?

For a closer look at how these valuation gaps stack up using earnings multiples, and what they could mean if the market moves toward the fair ratio, See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGS:FORM P/E Ratio as at Jul 2026
NasdaqGS:FORM P/E Ratio as at Jul 2026

Next Steps

With FormFactor pulling strong opinions on both sides, it makes sense to check the underlying data and move quickly to form your own stance using the 2 key rewards and 3 important warning signs

Looking for more investment ideas beyond FormFactor?

Do not stop with FormFactor. Broaden your watchlist now using targeted stock ideas so you are not relying on a single story for future returns.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.